PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $887 | -26.8% | 28,917 | -4.4% | 0.01% | -21.4% |
| Q2 2023 | $1,212 | -5.5% | 30,260 | -3.7% | 0.01% | -6.7% |
| Q1 2023 | $1,282 | +4.0% | 31,419 | -1.6% | 0.02% | 0.0% |
| Q4 2022 | $1,233 | -99.9% | 31,940 | +0.7% | 0.02% | -34.8% |
| Q3 2022 | $1,687,000 | -15.8% | 31,725 | -7.7% | 0.02% | -8.0% |
| Q2 2022 | $2,003,000 | -15.5% | 34,362 | +10.6% | 0.02% | 0.0% |
| Q1 2022 | $2,371,000 | +25.0% | 31,072 | -1.5% | 0.02% | +38.9% |
| Q4 2021 | $1,897,000 | +4.5% | 31,542 | -2.7% | 0.02% | 0.0% |
| Q3 2021 | $1,815,000 | -1.8% | 32,427 | +6.5% | 0.02% | -5.3% |
| Q2 2021 | $1,848,000 | -11.2% | 30,462 | +2.6% | 0.02% | -17.4% |
| Q1 2021 | $2,080,000 | +2.8% | 29,690 | -12.2% | 0.02% | 0.0% |
| Q4 2020 | $2,023,000 | -15.3% | 33,810 | -14.9% | 0.02% | -20.7% |
| Q3 2020 | $2,388,000 | +14.6% | 39,737 | +0.0% | 0.03% | +7.4% |
| Q2 2020 | $2,084,000 | +69.3% | 39,727 | +8.2% | 0.03% | +42.1% |
| Q1 2020 | $1,231,000 | -13.7% | 36,717 | +16.5% | 0.02% | 0.0% |
| Q4 2019 | $1,427,000 | +22.2% | 31,512 | +2.6% | 0.02% | +18.8% |
| Q3 2019 | $1,168,000 | – | 30,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |